Combination of Autoantibody Signature with PSA Level Enables a Highly Accurate Blood-Based Differentiation of Prostate Cancer Patients from Patients with Benign Prostatic Hyperplasia
Petra Leidinger(Saarland University), Eckart Meese(Saarland University), Nicole Ludwig(Saarland University), Christian Harz(Saarland University), Bastian Keck(Friedrich-Alexander-Universität Erlangen-Nürnberg), Bernd Wullich(Friedrich-Alexander-Universität Erlangen-Nürnberg), Lisa Milchram(Austrian Institute of Technology), Angelika Werth(Beilstein-Institut), Martin Hart(Institute of Human Genetics), Hans‐Peter Lenhof(Saarland University), Andreas Weinhäusel(Austrian Institute of Technology), Andreas Keller(Helmholtz Institute for Pharmaceutical Research Saarland)
Cited by 17
Related Papers
EV-TRACK: transparent reporting and centralizing knowledge in extracellular vesicle research
|Nature Methods|2017|1.3k
Distribution of miRNA expression across human tissues
|Nucleic Acids Research|2016|1k
Comprehensive Transcriptional Analysis of Early-Stage Urothelial Carcinoma
|Cancer Cell|2016|660
A blood based 12-miRNA signature of Alzheimer disease patients
|Genome biology|2013|514
New insights into the Tyrolean Iceman's origin and phenotype as inferred by whole-genome sequencing
|Nature Communications|2012|464